Table 2 Investigating the relationship between changes in lung cancer characteristics over time and the introduction of low-dose computed tomography in a hospital cohort
| Â | LDCT exam volume |
|---|---|
Age (yrs, mean) | -0.843 (< 0.001) |
Lung cancer number | 0.730 (0.003) |
1-year survival rate | 0.912 (< 0.001) |
5-year survival rate | 0.964 (< 0.001) |
10-year survival rate | 0.939 (0.005) |
Lung cancer death | -0.778 (0.001) |
Stage 0 (number) | 0.747 (0.002) |
Stage I (number) | 0.861 (< 0.001) |
Stage II (number) | 0.352 (0.217) |
Stage III (number) | -0.637 (0.014) |
Stage IV (number) | 0.235 (0.418) |
Stage 0 (%) | 0.801 (0.001) |
Stage I (%) | 0.912 (< 0.001) |
Stage II (%) | 0.011 (0.971) |
Stage III (%) | -0.753 (0.002) |
Stage IV (%) | -0.615 (0.019) |